Positron Corporation : [Positron Corporation] Positron Seeks to Bolster Cardiac PET's Rubidium-82 Supply
02/02/2012 | 10:18am
February 2, 2012 -- PET developer Positron has labored
literally for decades to
make cardiac PET a clinical reality. The company's effort
was paying off until
late last year, when the market got sidetracked by a
disruption in the supply of
rubidium-82, the main cardiac PET radiopharmaceutical.
Positron's solution? Grow
your own.
Not literally grow it, [...]
You may view the latest post at
http://www.positron.com/?pw6
You received this e-mail because you asked to be notified
when new updates are
posted.
Best regards,
Positron Team
sales@positron.com
